INFLIXIMAB (IFX) - ANVISA Registration 80102511760
Access comprehensive regulatory information for INFLIXIMAB (IFX) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102511760 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MรDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including IMMUNDIAGNOSTIK AG, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80102511760
25351580029201604
04718143000194
Company Information
Dates and Status
Mar 27, 2017
VIGENTE
09/18/2025 19:00:01
INFLIXIMAB (IFX)
IDKmonitorยฎ Infliximab drug level ELISA
IMMUNDIAGNOSTIK AG
80464810919
May 05, 2025
INFLIXIMAB (IFX)
LISA-TRACKER INFLIXIMAB
BIOSYNEX SA
10338930321
Aug 05, 2024
INFLIXIMAB (IFX)
Famรญlia AFIAS Infliximab
BODITECH MED INC.
10350840426
Oct 20, 2022
INFLIXIMAB (IFX)
PROMONITOR IFX
PROGENIKA BIOPHARMA S.L.
80134860242
Jul 03, 2017

